These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1123 related items for PubMed ID: 26598424
1. Clinical Relevance of Incidental Prostatic Lesions on FDG-Positron Emission Tomography/Computerized Tomography-Should Patients Receive Further Evaluation? Reesink DJ, Fransen van de Putte EE, Vegt E, De Jong J, van Werkhoven E, Mertens LS, Bex A, van der Poel HG, van Rhijn BW, Horenblas S, Meijer RP. J Urol; 2016 Apr; 195(4 Pt 1):907-12. PubMed ID: 26598424 [Abstract] [Full Text] [Related]
2. Incidental abnormal FDG uptake in the prostate on 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography scans. Kang PM, Seo WI, Lee SS, Bae SK, Kwak HS, Min K, Kim W, Kang DI. Asian Pac J Cancer Prev; 2014 Apr; 15(20):8699-703. PubMed ID: 25374193 [Abstract] [Full Text] [Related]
6. Accuracy of FDG-PET/CT for Detection of Incidental Pre-Malignant and Malignant Colonic Lesions - Correlation with Colonoscopic and Histopathologic Findings. Kunawudhi A, Wong AK, Alkasab TK, Mahmood U. Asian Pac J Cancer Prev; 2016 Apr; 17(8):4143-7. PubMed ID: 27644675 [Abstract] [Full Text] [Related]
8. Clinical significance of incidental prostatic fluorine-18-fluorodeoxyglucose uptake in the diagnosis of infectious prostatitis in adult males. Lee GH, Lee JH. Nucl Med Commun; 2017 Jun; 38(6):523-528. PubMed ID: 28383319 [Abstract] [Full Text] [Related]
9. Is further evaluation needed for incidental focal uptake in the prostate in 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography images? Hwang I, Chong A, Jung SI, Hwang EC, Kim SO, Kang TW, Kwon DD, Park K, Ryu SB. Ann Nucl Med; 2013 Feb; 27(2):140-5. PubMed ID: 23076866 [Abstract] [Full Text] [Related]
10. Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy. How Kit N, Dugué AE, Sevin E, Allouache N, Lesaunier F, Joly F, Aide N. Nucl Med Commun; 2016 Apr; 37(4):348-55. PubMed ID: 26642435 [Abstract] [Full Text] [Related]
11. Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT. Lee MS, Cho JY, Kim SY, Cheon GJ, Moon MH, Oh S, Lee J, Lee S, Woo S, Kim SH. J Magn Reson Imaging; 2017 Feb; 45(2):597-609. PubMed ID: 27586519 [Abstract] [Full Text] [Related]
12. Prevalence and risk of cancer of incidental uptake in prostate identified by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Yang Z, Hu S, Cheng J, Xu J, Shi W, Zhu B, Zhang Y, Yao Z, Pan H, Zhang Y. Clin Imaging; 2014 Feb; 38(4):470-474. PubMed ID: 24629790 [Abstract] [Full Text] [Related]
13. 68Ga-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study. Lopci E, Saita A, Lazzeri M, Lughezzani G, Colombo P, Buffi NM, Hurle R, Marzo K, Peschechera R, Benetti A, Zandegiacomo S, Pasini L, Lista G, Cardone P, Castello A, Maffei D, Balzarini L, Chiti A, Guazzoni G, Casale P. J Urol; 2018 Jul; 200(1):95-103. PubMed ID: 29409824 [Abstract] [Full Text] [Related]
14. Significance of incidental focal uptake in prostate on 18-fluoro-2-deoxyglucose positron emission tomography CT images. Han EJ, H O J, Choi WH, Yoo IR, Chung SK. Br J Radiol; 2010 Nov; 83(995):915-20. PubMed ID: 20965901 [Abstract] [Full Text] [Related]
15. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer. Minamimoto R, Loening A, Jamali M, Barkhodari A, Mosci C, Jackson T, Obara P, Taviani V, Gambhir SS, Vasanawala S, Iagaru A. J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167 [Abstract] [Full Text] [Related]
16. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K. Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [Abstract] [Full Text] [Related]
17. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system. Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF. Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008 [Abstract] [Full Text] [Related]
18. Detection of incidental colorectal pathology on positron emission tomography/computed tomography. Mui M, Akhurst T, Warrier SK, Lynch AC, Heriot AG. ANZ J Surg; 2018 Mar; 88(3):E122-E126. PubMed ID: 27580915 [Abstract] [Full Text] [Related]
19. Clinical significance of 18F-FDG-PET/CT for detection of incidental pre-malignant and malignant colonic lesions: correlation with colonoscopic and histopathological results. Zhang Y, Han J, Li J, Cao J, Zhou Y, Deng S, Zhang B, Yang Y. J Cancer Res Clin Oncol; 2024 May 20; 150(5):265. PubMed ID: 38769201 [Abstract] [Full Text] [Related]
20. Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: results of a prospective study. Peng J, He Y, Xu J, Sheng J, Cai S, Zhang Z. Colorectal Dis; 2011 Nov 20; 13(11):e374-8. PubMed ID: 21831098 [Abstract] [Full Text] [Related] Page: [Next] [New Search]